Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 159

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells

Open access
MENENDEZ, JAVIER, Joven, Jorge, CUFÍ, SÍLVIA, COROMINAS-FAJA, BRUNA, Oliveras-Ferraros, Cristina, CUYÀS, ELISABET, Martin-Castillo, Begoña, López-Bonet, Eugeni, ALARCÓN, TOMÁS, Vazquez-Martin, Alejandro·2013·Cell Cycle

Abstract

When fighting cancer, knowledge on metabolism has always been important. Today, it matters more than ever. The restricted cataloging of cancer genomes is quite unlikely to achieve the task of curing cancer, unless it is integrated into metabolic networks that respond to and influence the constantly evolving cancer stem cell (CSC) cellular states. Once the genomic era of carcinogenesis had pushed the 1920s Otto Warburg's metabolic cancer hypothesis into obscurity for decades, the most recent studies begin to support a new developing paradigm, in which the molecular logic behind the conversion of non-CSCs into CSCs can be better understood in terms of the "metabolic facilitators" and "metabolic impediments" that operate as proximate openings and roadblocks, respectively, for the transcriptional events and signal transduction programs that ultimately orchestrate the intrinsic and/or microenvironmental paths to CSC cellular states. Here we propose that a profound understanding of how human carcinomas install a proper "Warburg effect version 2.0" allowing them to "run" the CSCs' "software" programs should guide a new era of metabolo-genomic-personalized cancer medicine. By viewing metabolic reprogramming of CSCs as an essential characteristic that allows dynamic, multidimensional and evolving cancer populations to compete successfully for their expansion on the organism, we now argue that CSCs bioenergetics might be another cancer hallmark. A definitive understanding of metabolic reprogramming in CSCs may complement or to some extent replace, the 30-y-old paradigm of targeting oncogenes to treat human carcinomas, because it can be possible to metabolically create non-permissive or "hostile" metabotypes to prevent the occurrence of CSC cellular states with tumor- and metastasis-initiating capacity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/cc.24479

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 159

Metadata

Authors
MENENDEZ, J., Joven, J., CUFÍ, S., COROMINAS-FAJA, B., Oliveras-Ferraros, C., CUYÀS, E., Martin-Castillo, B., López-Bonet, E., ALARCÓN, T., & Vazquez-Martin, A.
Venue
Cell Cycle
Published
2013-04-15
Volume
12
Issue
8
Pages
1166-1179
ISSN
  • 1538-4101 (ISSN-L)
  • 1551-4005
OpenAlex
W2041094651
Cited by
159
References
20
FWCI
6.21
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells. https://app.cochat.ai/papers/10.4161/cc.24479
The paper
MENENDEZ, J., Joven, J., CUFÍ, S., COROMINAS-FAJA, B., Oliveras-Ferraros, C., CUYÀS, E., Martin-Castillo, B., López-Bonet, E., ALARCÓN, T., & Vazquez-Martin, A. (2013). The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells. Cell Cycle. https://doi.org/10.4161/cc.24479

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.